GLOBALMalwareManufacturingManufacturingRansomwareQilinRansom DemandedActor NamedMedium
dalton.com
bd_36c520828bcbbc3f · schema v1 · pii pii-v1
Full breach record for dalton.com →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Qilin on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Group activity: ManufacturingDiscovered: 2025-10-16
Source: Ransomware.live
Post text · scraped from the leak site
Founded in 1986, Dalton Pharma Services is a contract pharmaceutical company providing a full range of development and manufacturing services to pharmaceutical and research companies worldwide. 1.The document is a bank statement from MUFG Ba ...
Tracked as a single-filing incident — the only disclosure on record for this event so far.Unverified claimView incident
No regulatory filing corroborates this yet. If an SEC 8-K, state-AG notice, or victim statement lands, DisclosureLens will merge it into an incident and link it here.
Source provenance
- Source URL
- https://www.ransomware.live/
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Oct 16, 2025
- Raw hash
- cb33408d863dc3f4b3c8004b7eacb46b4ce77279f3013bb7f58d44a9dd287441
Reporting entity
- Name
- qilin
Victim entity
- Name
- dalton.comnorm: daltoncom
- Domain
- dalton.com
- Industry
- Manufacturingllm
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· qilin
- Threat actor
- QilinExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.